Mycobacterium tuberculosis Biofilms: Immune Responses, Role in TB Pathology, and Potential Treatment.

IF 6.2 Q1 IMMUNOLOGY
ImmunoTargets and Therapy Pub Date : 2024-07-03 eCollection Date: 2024-01-01 DOI:10.2147/ITT.S455744
Muluneh Assefa, Getu Girmay
{"title":"<i>Mycobacterium tuberculosis</i> Biofilms: Immune Responses, Role in TB Pathology, and Potential Treatment.","authors":"Muluneh Assefa, Getu Girmay","doi":"10.2147/ITT.S455744","DOIUrl":null,"url":null,"abstract":"<p><p>Tuberculosis (TB) is a major public health problem worldwide, and the burden of drug-resistant TB is rapidly increasing. Although there are literatures about the <i>Mtb</i> biofilms, their impact on immune responses has not yet been summarized. This review article provides recent knowledge on <i>Mycobacterium tuberculosis</i> (<i>Mtb</i>) biofilm-immunity interactions, their importance in pulmonary TB pathology, and immune-based therapy targeting <i>Mtb</i> biofilms. Pellicle/biofilm formation in <i>Mtb</i> contributes to drug resistance, persistence, chronicity, surface attachment, transfer of resistance genes, and modulation of the immune response, including reduced complement activation, changes in the expression of antigenic proteins, enhanced activation of T-lymphocytes, elevated local IFNγ+ T cells, and strong antibody production. The combination of anti-TB drugs and anti-biofilm agents has recently become an effective strategy to improve TB treatment. Additionally, immune-targeted therapy and biofilm-based vaccines are crucial for TB prevention.</p>","PeriodicalId":30986,"journal":{"name":"ImmunoTargets and Therapy","volume":"13 ","pages":"335-342"},"PeriodicalIF":6.2000,"publicationDate":"2024-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11227863/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ImmunoTargets and Therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2147/ITT.S455744","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Tuberculosis (TB) is a major public health problem worldwide, and the burden of drug-resistant TB is rapidly increasing. Although there are literatures about the Mtb biofilms, their impact on immune responses has not yet been summarized. This review article provides recent knowledge on Mycobacterium tuberculosis (Mtb) biofilm-immunity interactions, their importance in pulmonary TB pathology, and immune-based therapy targeting Mtb biofilms. Pellicle/biofilm formation in Mtb contributes to drug resistance, persistence, chronicity, surface attachment, transfer of resistance genes, and modulation of the immune response, including reduced complement activation, changes in the expression of antigenic proteins, enhanced activation of T-lymphocytes, elevated local IFNγ+ T cells, and strong antibody production. The combination of anti-TB drugs and anti-biofilm agents has recently become an effective strategy to improve TB treatment. Additionally, immune-targeted therapy and biofilm-based vaccines are crucial for TB prevention.

结核分枝杆菌生物膜:免疫反应、在结核病理中的作用以及潜在的治疗方法。
结核病(TB)是全球主要的公共卫生问题,耐药性结核病的负担正在迅速加重。虽然已有关于 Mtb 生物膜的文献,但尚未总结它们对免疫反应的影响。这篇综述文章介绍了结核分枝杆菌(Mtb)生物膜与免疫相互作用的最新知识、它们在肺结核病理学中的重要性以及针对Mtb生物膜的免疫疗法。Mtb细胞膜/生物膜的形成可导致耐药性、持久性、慢性化、表面附着、耐药基因的转移以及免疫反应的调节,包括补体激活的降低、抗原蛋白表达的改变、T淋巴细胞激活的增强、局部IFNγ+ T细胞的升高以及抗体的产生。最近,抗结核药物和抗生物膜药物的联合使用已成为改善结核病治疗的有效策略。此外,免疫靶向疗法和基于生物膜的疫苗对于结核病的预防也至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
16.50
自引率
0.00%
发文量
7
审稿时长
16 weeks
期刊介绍: Immuno Targets and Therapy is an international, peer-reviewed open access journal focusing on the immunological basis of diseases, potential targets for immune based therapy and treatment protocols employed to improve patient management. Basic immunology and physiology of the immune system in health, and disease will be also covered.In addition, the journal will focus on the impact of management programs and new therapeutic agents and protocols on patient perspectives such as quality of life, adherence and satisfaction.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信